Other abnormalities seen in obesity include accelerated formation of advanced glycation end products (AGEs), subsequent activation of their receptor, and changes in arginine metabolism, which may play a role in the pathogenesis of asthma and may be modulated by the anti-inflammatory incretin GLP-1. This evidence concerns the gene GLP1R and obesity disorder.